Biomacromolecular drug synthesis device

Abstract

The invention discloses a biomacromolecular drug synthesis device which structurally comprises a base, a motor, an operation board, a reaction kettle and a driving machine, wherein the reaction kettle is installed on the base, the reaction kettle is matched with the operation board through the motor and the driving machine in an electrical connection mode, the reaction kettle comprises an inner groove, a sliding ring, an auxiliary inlet, a powder basin and a kettle body, the inner groove is connected into the kettle body, the powder basin is connected between the inner groove and the kettle body through a sliding ring, the auxiliary inlet is formed in the powder basin, a jacking piece and a lower limit device are arranged at the auxiliary inlet, and the jacking piece and the lower limit device are matched on the material guide plate, so that when catalytic liquid excites relative airflow movement in the kettle body, the airflow impacts and expands the jacking piece in the forward direction, the lower limit device is driven by the jacking piece to directly receive the air flow and turn downwards, and the lower limit device not only can block raised dust, but also can crush agglomerates.

Description

technical field [0001] The invention relates to the technical field of research and development of biomacromolecular drugs, in particular, a synthesis device for biomacromolecular drugs. Background technique [0002] Drugs are substances used to prevent, treat and diagnose diseases. Many drugs need to be synthesized under different parameter conditions. The existing drug synthesis devices design the structure, function and configuration accessories of the reaction device according to the reaction conditions. The conditions and steps are used to set the structure, and to regulate important parameters such as temperature, pressure, mechanical control, and reaction concentration in the reaction process, so as to ensure that the drug can be better prepared in the synthesis device and obtain a better drug. However, the existing biomacromolecule drug synthesis devices are prone to the following disadvantages when used: [0003] Because a variety of pharmaceuticals and drugs often...

AI Technical Summary

Problems solved by technology

[0003] Because a variety of pharmaceuticals and drugs often need catalytic liquid to catalyze them when they are synthesized, they are usually dripped directly from the reactor. When the catalytic liquid drops on the powder pile, relative air movement will be aroused in the reactor. Not only will there be dust flying, which will make the air flow return to the inlet along the original path, but it will also quickly form agglomerates with the powder at the place where it falls and pile up on the powder pile, causing the catalytic liquid to have a negative impact on the quality of the later drug synthesis, and it is impossible to obtain all medicine needed

Images